<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>19(6)</volume><submitter>Mazumder S</submitter><pubmed_abstract>We characterize nicotine exposure in the U.S. population by measuring urinary nicotine and its major (cotinine, trans-3'-hydroxycotinine) and minor (nicotine 1'-oxide, cotinine N-oxide, and 1-(3-pyridyl)-1-butanol-4-carboxylic acid, nornicotine) metabolites in participants from the 2015-2016 National Health and Nutrition Examination Survey. This is one of the first U.S. population-based urinary nicotine biomarker reports using the derived total nicotine equivalents (i.e., TNEs) to characterize exposure. Serum cotinine data is used to stratify tobacco non-users with no detectable serum cotinine (-sCOT), non-users with detectable serum cotinine (+sCOT), and individuals who use tobacco (users). The molar concentration sum of cotinine and trans-3'-hydroxycotinine was calculated to derive the T</pubmed_abstract><journal>International journal of environmental research and public health</journal><pagination>3660</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8955498</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Nicotine Exposure in the U.S. Population: Total Urinary Nicotine Biomarkers in NHANES 2015-2016.</pubmed_title><pmcid>PMC8955498</pmcid><pubmed_authors>Bendik PB</pubmed_authors><pubmed_authors>Feng J</pubmed_authors><pubmed_authors>Luo Z</pubmed_authors><pubmed_authors>Pine BN</pubmed_authors><pubmed_authors>Mazumder S</pubmed_authors><pubmed_authors>Shia W</pubmed_authors><pubmed_authors>Alexander JR</pubmed_authors><pubmed_authors>Blount BC</pubmed_authors><pubmed_authors>Zhu W</pubmed_authors><pubmed_authors>Achilihu H</pubmed_authors><pubmed_authors>Sosnoff CS</pubmed_authors><pubmed_authors>Wang L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Nicotine Exposure in the U.S. Population: Total Urinary Nicotine Biomarkers in NHANES 2015-2016.</name><description>We characterize nicotine exposure in the U.S. population by measuring urinary nicotine and its major (cotinine, trans-3'-hydroxycotinine) and minor (nicotine 1'-oxide, cotinine N-oxide, and 1-(3-pyridyl)-1-butanol-4-carboxylic acid, nornicotine) metabolites in participants from the 2015-2016 National Health and Nutrition Examination Survey. This is one of the first U.S. population-based urinary nicotine biomarker reports using the derived total nicotine equivalents (i.e., TNEs) to characterize exposure. Serum cotinine data is used to stratify tobacco non-users with no detectable serum cotinine (-sCOT), non-users with detectable serum cotinine (+sCOT), and individuals who use tobacco (users). The molar concentration sum of cotinine and trans-3'-hydroxycotinine was calculated to derive the T</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-04T23:33:01.108Z</modification><creation>2025-02-19T03:58:49.206Z</creation></dates><accession>S-EPMC8955498</accession><cross_references><pubmed>35329347</pubmed><doi>10.3390/ijerph19063660</doi></cross_references></HashMap>